{"resourceType":"Condition","id":"48952","meta":{"versionId":"1","lastUpdated":"2022-12-21T09:47:26.322+01:00","source":"#Hsx3mAgds9DhRuHn","profile":["http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp"]},"language":"ES","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/condition-assertedDate","valueDateTime":"2014-05-15"},{"url":"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-histology-morphology-behavior","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"9836/3","display":"Leucemia linfoblástica de células B precursoras  ( maligno )  "}]}}],"bodySite":[{"extension":[{"url":"http://hl7.eu/fhir/ig/pcsp/StructureDefinition/mcode-laterality-qualifier","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/data-absent-reason","code":"not-applicable","display":"No aplicable"}]}}],"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"C42","display":"Médula ósea  [C42 SISTEMAS HEMATOPOYÉTICO Y RETICULOENDOTELIAL ] "}]}],"subject":{"reference":"Patient/48151","type":"Patient"},"stage":[{"summary":{"text":"Muy alto riesgo"}}],"evidence":[{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"106221001","display":"Evidencia de Marcadores Genéticos"}],"text":"BCR/ABL, MLL, E1A2, TEL/AML1 negativos"}]}]}
